Skip to main content

Table 4 Medication use related to index hospitalization

From: The importance of having good quality indicators for care of patients with COPD: a look at hospital readmission rates

  Total group No hospitalization the year before the index hospitalization  ≥ 1 hospitalization the year before the index hospitalization
  Without re-admission (n = 466) With re-admission (n = 737) p-value Without re-admission (n = 140) With re-admission (n = 99) p-value Without re-admission (n = 326) With re-admission (n = 638) p-value
ICS use 6 months before index hospitalization (%) 16.1% 21.1% 0.03 10.7% 10.1% 0.87 18.4% 22.9% 0.11
ICS use 3 months after index hospitalization (%) 14.1% 17.8% 0.10 8.5% 10.1% 0.69 16.6% 19.0% 0.36
LAMA use 6 months before index hospitalization (%) 34.8% 48.4%  < 0.0001 22.8% 26.3% 0.54 39.9% 51.9% 0.0004
LAMA use 3 months after index hospitalization (%) 36.9% 51.8%  < 0.0001 28.6% 41.1% 0.04 40.5% 53.4% 0.0001
SABA use 6 months before index hospitalization (%) 42.3%% 49.8% 0.01 33.5% 43.4% 0.12 46.0% 50.8% 0.03
SABA use 3 months after index hospitalization (%) 43.5% 46.4% 0.33 36.4% 41.4% 0.43 46.6% 47.1% 0.87
LABA use 6 months before index hospitalization (%) 4.9% 6.6% 0.22 2.8% 3.0% 0.93 5.8% 7.2% 0.42
LABA use 3 months after index hospitalization (%) 5.4% 8.1% 0.07 6.4% 9.1% 0.44 4.9% 8.0% 0.07
  1. *Readmission within 90 days
  2. ICS Inhaled corticosteroids; LAMA long-acting muscarinic antagonist, SABA Short-acting beta agonist